logo
episode-header-image
Apr 2021
11m 15s

The U.S. Vaccination Rate Continues To S...

NPR
About this episode
Short Wave's Emily Kwong talks with NPR health correspondent Allison Aubrey about some of the latest coronavirus news, including the return of the Johnson & Johnson vaccine in the U.S. and vaccine outreach in harder to reach communities.

Have questions about the latest coronavirus headlines? Email us at shortwave@npr.org and we might cover it on a future episode.

See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.

NPR Privacy Policy
Up next
Yesterday
The psychology behind why you dread small talk
Do you avoid small talk in the office, or with your neighbor in the elevator? If so, you might want to give it a chance. According to a study just published in the Journal of Personality and Social Psychology, even when participants were primed that a conversation would be boring ... Show More
9m 56s
Apr 15
A new approach to brain health, one neuron at a time
Neuroscientist Paul Nuyujukian likens the brain to a stadium full of people. To eavesdrop on the crowd you could put a microphone in the middle of the stadium. But to understand the conversations you need to record individual people. He thinks about the brain the same way. To und ... Show More
13m 18s
Apr 14
Is there still a gender gap in medical research?
When you go to the doctor’s office, your doctor has to figure out which treatment is best for you. Physicians rely on medical research and clinical trials to make sure those treatments are safe and effective. But that research has not always been inclusive, which impacts patient ... Show More
13m 18s
Recommended Episodes
Feb 2021
Third Vaccine On The Way, Fauci Hails 'Spectacular Results'
A third COVID-19 vaccine could receive emergency use authorization from the Food and Drug Administration this month. The vaccine made by Johnson & Johnson is 66% effective in preventing moderate to severe disease, according to a global study. Combined with the two vaccines curren ... Show More
12m 29s
Jan 2021
Why U.S. Vaccinations Started Slow And What We Know About The New Coronavirus Variant
Initially, U.S. officials predicted that as many as 20 million Americans would be fully vaccinated before the end of 2020. And while that many vaccine doses were distributed, only a fraction of them have been administered. The federal government has given states control over dist ... Show More
12m 21s
Jan 2021
Why Are U.S. Coronavirus Cases Falling? And Will the Trend Last?
<p>The number of new coronavirus cases in the United States is falling, but has the country turned a corner in the pandemic? And what kind of threats do the new variants pose to people and to the vaccine rollout?</p><p>Today, we discuss the latest in the quest to stamp out the pa ... Show More
26m 17s
Nov 2020
A Vaccine Breakthrough
<p>It’s a dark time in the struggle with the coronavirus, particularly in the United States, where infections and hospitalizations have surged.</p><p>But amid the gloom comes some light: A trial by the drug maker Pfizer has returned preliminary results suggesting that its vaccine ... Show More
24m 29s
Mar 2021
The State of Vaccinations
<p>The United States has never undertaken a vaccination campaign of the scale and speed of the Covid-19 program. Despite a few glitches, the country appears to be on track to offer shots to all adults who want one by May 1.</p><p>We look at the ups and downs in the American vacci ... Show More
26m 42s
Dec 2020
Vaccine hesitancy, the next pandemic hurdle
As the Pfizer-BioNTech vaccine rolls out across the country, and other vaccines await imminent regulatory approval, many public health experts are focusing on the issue of vaccine hesitancy. Canada's Chief Public Health Officer Dr. Theresa Tam has spoken out about the "moveable m ... Show More
31m 47s
Apr 2020
The Race for a Vaccine
<p>Scientists are racing to make a vaccine for the coronavirus, collaborating across borders in what is usually a secretive and competitive field. But their cooperation has been complicated by national leaders trying to buy first claim on any breakthrough. Today, we explore how t ... Show More
24m 32s
Dec 2020
Race for the Vaccine
On the same day the COVID-19 death toll surpassed 300,000 in the United States, the first vaccines are being administered, finally giving millions of Americans hope for a better future and a return to normalcy. We explore how officials expect to deliver a safe and effective vacci ... Show More
37m 42s
Listen to millions of songs and podcasts on Anghami